| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
On June 12, 2024, Annovis Bio, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting") virtually. At the Annual Meeting, three proposals were submitted to the Company's stockholders and all matters voted upon were approved with the required votes. The proposals are outlined below and further described in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission.
At the Annual Meeting, a total of 7,278,396 shares of the Company's common stock, or 66.10% of the common stock outstanding as of April 18, 2024, the record date for the Annual Meeting, were represented virtually or by proxy.
The following is a brief description of the final voting results for each of the three proposals submitted at the Annual Meeting on June 12, 2024:
1. Election of Directors
All of the following five nominees were elected to the Company's Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.
| Nominee | For | Withheld |
Broker Non-Vote |
|||||||||
| Michael Hoffman | 3,856,586 | 122,626 | 3,299,184 | |||||||||
| Maria Maccecchini | 3,888,261 | 90,951 | 3,299,184 | |||||||||
| Claudine Bruck | 3,827,976 | 151,236 | 3,299,184 | |||||||||
| Reid McCarthy | 3,845,664 | 133,548 | 3,299,184 | |||||||||
| Mark White | 3,825,922 | 153,290 | 3,299,184 |
2. Amendment to the Company's 2019 Equity Incentive Plan
Stockholders have approved an amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan, to add 1,000,000 shares to the Plan's share reserve, in accordance with the voting results listed below:
Attachments
Disclaimer
Annovis Bio Inc. published this content on 13 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 June 2024 10:07:12 UTC.